Meribank Biotech Co

Meribank Biotech Co Inventory

The Inventory of Meribank Biotech Co (4724.TWO) as of Oct 16, 2026 is 6.42 M TWD. In the previous year, Inventory was 11.24 M TWD — a change of -42.88% (lower).

Inventory

6.42 MTWD

YoY

-42.88%

Last updated:

Inventory of Meribank Biotech Co is 2025 6.42 M TWD. Inventory of Meribank Biotech Co was 2024 11.24 M TWD. It decreases by -42.88% lower compared to the previous year.

The Meribank Biotech Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2019
2.65 M TWD
Jan 1, 2020
2.94 M TWD
Jan 1, 2021
3.60 M TWD
Jan 1, 2022
8.45 M TWD
Jan 1, 2023
6.91 M TWD
Jan 1, 2024
11.24 M TWD
Jan 1, 2025
6.42 M TWD
The Meribank Biotech Co Inventory history
YEARInventoryYoY
6.42 MTWD-42.88%
11.24 MTWD+62.79%
6.91 MTWD-18.22%
8.45 MTWD+134.35%
3.60 MTWD+22.71%
2.94 MTWD+10.75%
2.65 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Meribank Biotech Co Stock analysis

What does Meribank Biotech Co do? Meribank Biotech Co Ltd, listed on the Taiwan Stock Exchange with ticker 4724.TWO and ISIN TW0004724000, is headquartered in Taipei City, Taiwan. The company went public on June 16, 2023. Meribank Biotech focuses on the research and development of stem cell technologies, specifically providing cord blood (hematopoietic stem cells) storage and application services. It also offers storage and application services for placenta and umbilical cord (mesenchymal stem cells), as well as peripheral blood stem cell storage and application services. The company is involved in promoting stem cell transplantation applications and developing new stem cell processing technologies. Additionally, Meribank Biotech engages in the development of allogeneic umbilical cord mesenchymal stem cell manufacturing and therapeutic applications. The firm’s website is https://www.meribank.com.tw/. No further details on its sector, industry, or specific financial figures are provided in the available information. The company operates within the biotechnology sector, concentrating on stem cell-related services and technologies. Its IPO date marks its entry into the public market, with operations centered on the storage and application of various stem cell types for medical and therapeutic purposes. Meribank Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meribank Biotech Co stock

Inventory of Meribank Biotech Co is 6.42 M TWD in 2025.

Inventory of Meribank Biotech Co changed from 11.24 M TWD to 6.42 M TWD, representing a -42.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Meribank Biotech Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Meribank Biotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Meribank Biotech Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Meribank Biotech Co